Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-04 01:35 | 2026-02-27 | AUPH | Aurinia Pharmaceuticals Inc. | TANG KEVIN | Director | Pharmaceutical Preparations | BUY | $14.10 | 900,000 | $12,688,830 | 12,229,500 | +7.9% |
| 2025-08-05 23:07 | 2025-08-01 | AUPH | Aurinia Pharmaceuticals Inc. | Keenan Greg | Officer; Chief Medical Officer | Pharmaceutical Preparations | SALE | $10.50 | 20,000 | $210,000 | 133,484 | -13.0% |
| 2025-08-06 00:31 | 2025-08-01 | AUPH | Aurinia Pharmaceuticals Inc. | TANG KEVIN | Director | Pharmaceutical Preparations | BUY | $10.45 | 1,300,000 | $13,589,940 | 11,329,500 | +13.0% |
| 2025-03-08 01:25 | 2025-03-07 | AUPH | Aurinia Pharmaceuticals Inc. | Keenan Greg | Officer; Chief Medical Officer | Pharmaceutical Preparations | SALE | $8.23 | 8,305 | $68,350 | 153,484 | -5.1% |
| 2025-03-05 04:59 | 2025-03-03 | AUPH | Aurinia Pharmaceuticals Inc. | Keenan Greg | Officer; Chief Medical Officer | Pharmaceutical Preparations | SALE | $8.00 | 12,239 | $97,912 | 161,789 | -7.0% |
| 2025-03-05 04:58 | 2025-03-03 | AUPH | Aurinia Pharmaceuticals Inc. | Miller Joseph M | Officer; Chief Financial Officer | Pharmaceutical Preparations | SALE | $7.96 | 118,013 | $939,608 | 577,361 | -17.0% |
| 2025-03-05 04:57 | 2025-03-03 | AUPH | Aurinia Pharmaceuticals Inc. | Robertson Stephen P. | Officer; EVP, General Counsel | Pharmaceutical Preparations | SALE | $7.96 | 122,479 | $975,227 | 509,276 | -19.4% |
| 2025-03-05 04:56 | 2025-03-03 | AUPH | Aurinia Pharmaceuticals Inc. | Donley Matthew Maxwell | Officer; Chief Operating Officer | Pharmaceutical Preparations | SALE | $7.96 | 124,893 | $994,423 | 680,465 | -15.5% |
| 2025-03-05 05:02 | 2025-03-03 | AUPH | Aurinia Pharmaceuticals Inc. | Greenleaf Peter | Director, Officer; Chief Executive Officer | Pharmaceutical Preparations | SALE | $7.96 | 360,540 | $2,871,124 | 1,788,945 | -16.8% |
| 2025-03-05 01:03 | 2025-02-28 | AUPH | Aurinia Pharmaceuticals Inc. | TANG KEVIN | Director | Pharmaceutical Preparations | BUY | $7.95 | 1,600,000 | $12,713,120 | 10,029,500 | +19.0% |
| 2024-12-10 00:52 | 2024-12-05 | AUPH | Aurinia Pharmaceuticals Inc. | TANG KEVIN | Director | Pharmaceutical Preparations | BUY | $9.02 | 1,200,000 | $10,821,960 | 8,429,500 | +16.6% |
| 2024-11-13 03:20 | 2024-11-11 | AUPH | Aurinia Pharmaceuticals Inc. | Smith Karen L. | Director | Pharmaceutical Preparations | OPT+S | $8.43 | 5,241 | $44,182 | 12,672 | -29.3% |
| 2024-11-13 03:29 | 2024-11-11 | AUPH | Aurinia Pharmaceuticals Inc. | Bailey Jeffrey Allen | Director | Pharmaceutical Preparations | OPT+S | $8.43 | 4,557 | $38,416 | 13,356 | -25.4% |
| 2024-08-08 23:06 | 2024-08-06 | AUPH | Aurinia Pharmaceuticals Inc. | Habig Scott Michael | Officer; Chief Commercial Officer | Pharmaceutical Preparations | SALE | $5.31 | 18,249 | $96,902 | 456,338 | -3.8% |
| 2024-05-22 23:16 | 2024-05-21 | AUPH | Aurinia Pharmaceuticals Inc. | Balakrishnan Brinda | Director | Pharmaceutical Preparations | SALE | $5.74 | 520 | $2,985 | 17,523 | -2.9% |
| 2024-05-22 23:14 | 2024-05-21 | AUPH | Aurinia Pharmaceuticals Inc. | Billen Daniel | Director | Pharmaceutical Preparations | SALE | $5.74 | 5,252 | $30,146 | 28,141 | -15.7% |
| 2024-05-22 23:11 | 2024-05-21 | AUPH | Aurinia Pharmaceuticals Inc. | Jayne David R.W. | Director | Pharmaceutical Preparations | SALE | $5.74 | 4,946 | $28,390 | 44,364 | -10.0% |
| 2024-05-22 23:09 | 2024-05-21 | AUPH | Aurinia Pharmaceuticals Inc. | Leversage Jill | Director | Pharmaceutical Preparations | SALE | $5.74 | 5,610 | $32,201 | 12,918 | -30.3% |
| 2024-05-22 23:07 | 2024-05-21 | AUPH | Aurinia Pharmaceuticals Inc. | MacKay-Dunn R. Hector | Director | Pharmaceutical Preparations | SALE | $5.74 | 5,630 | $32,316 | 18,595 | -23.2% |
| 2024-03-08 00:44 | 2024-03-06 | AUPH | Aurinia Pharmaceuticals Inc. | Miller Joseph M | Officer; Chief Financial Officer | Pharmaceutical Preparations | SALE | $5.60 | 34,811 | $194,942 | 495,928 | -6.6% |
| 2024-03-08 00:43 | 2024-03-06 | AUPH | Aurinia Pharmaceuticals Inc. | Donley Matthew Maxwell | Officer; EVP, Ops & Strategy | Pharmaceutical Preparations | SALE | $5.51 | 40,665 | $224,064 | 584,072 | -6.5% |
| 2024-03-08 00:42 | 2024-03-06 | AUPH | Aurinia Pharmaceuticals Inc. | Habig Scott Michael | Officer; Chief Commercial Officer | Pharmaceutical Preparations | SALE | $5.60 | 17,777 | $99,551 | 474,587 | -3.6% |
| 2024-03-08 00:41 | 2024-03-06 | AUPH | Aurinia Pharmaceuticals Inc. | Robertson Stephen P. | Officer; EVP, General Counsel | Pharmaceutical Preparations | SALE | $5.60 | 57,745 | $323,372 | 443,824 | -11.5% |
| 2024-03-08 00:46 | 2024-03-06 | AUPH | Aurinia Pharmaceuticals Inc. | Greenleaf Peter | Director, Officer; Chief Executive Officer | Pharmaceutical Preparations | SALE | $5.60 | 126,981 | $711,094 | 1,522,114 | -7.7% |
| 2024-03-01 00:11 | 2024-02-27 | AUPH | Aurinia Pharmaceuticals Inc. | Knappertz Volker | Officer; EVP, Research and Development | Pharmaceutical Preparations | SALE | $6.10 | 4,930 | $30,073 | 319,128 | -1.5% |
| 2024-02-23 00:35 | 2024-02-20 | AUPH | Aurinia Pharmaceuticals Inc. | Knappertz Volker | Officer; EVP, Research and Development | Pharmaceutical Preparations | SALE | $5.48 | 25,146 | $137,800 | 324,058 | -7.2% |
| 2024-02-23 00:33 | 2024-02-20 | AUPH | Aurinia Pharmaceuticals Inc. | Habig Scott Michael | Officer; Chief Commercial Officer | Pharmaceutical Preparations | SALE | $5.48 | 15,867 | $86,951 | 492,364 | -3.1% |
| 2024-02-23 00:19 | 2023-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Robertson Stephen P. | Officer; EVP, General Counsel | Pharmaceutical Preparations | SALE | $8.78 | 19,644 | $172,474 | 303,122 | -6.1% |
| 2024-02-23 00:17 | 2023-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Miller Joseph M | Officer; Chief Financial Officer | Pharmaceutical Preparations | SALE | $8.78 | 11,398 | $100,074 | 331,112 | -3.3% |
| 2024-02-23 00:15 | 2023-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Greenleaf Peter | Director, Officer; Chief Executive Officer | Pharmaceutical Preparations | SALE | $8.78 | 33,047 | $290,153 | 982,671 | -3.3% |
| 2023-05-24 00:19 | 2023-05-23 | AUPH | Aurinia Pharmaceuticals Inc. | Jayne David R.W. | Director | Pharmaceutical Preparations | OPT+S | $11.26 | 8,733 | $98,334 | 49,310 | -15.0% |
| 2023-05-24 00:17 | 2023-05-23 | AUPH | Aurinia Pharmaceuticals Inc. | Billen Daniel | Director | Pharmaceutical Preparations | OPT+S | $11.26 | 4,650 | $52,359 | 33,393 | -12.2% |
| 2023-05-24 00:16 | 2023-05-23 | AUPH | Aurinia Pharmaceuticals Inc. | MacKay-Dunn R. Hector | Director | Pharmaceutical Preparations | OPT+S | $11.26 | 4,818 | $54,251 | 24,225 | -16.6% |
| 2023-05-24 00:14 | 2023-05-23 | AUPH | Aurinia Pharmaceuticals Inc. | Leversage Jill | Director | Pharmaceutical Preparations | OPT+S | $11.26 | 4,815 | $54,217 | 18,528 | -20.6% |
| 2023-05-24 00:18 | 2023-05-19 | AUPH | Aurinia Pharmaceuticals Inc. | Hagan Joseph P | Director | Pharmaceutical Preparations | OPT+S | $10.58 | 272 | $2,878 | 11,961 | -2.2% |
| 2023-03-07 00:29 | 2023-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Miller Joseph M | Officer; Chief Financial Officer | Pharmaceutical Preparations | SALE | $8.94 | 11,296 | $100,986 | 331,214 | -3.3% |
| 2023-03-07 00:29 | 2023-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Robertson Stephen P. | Officer; EVP, General Counsel | Pharmaceutical Preparations | SALE | $8.94 | 19,402 | $173,454 | 303,364 | -6.0% |
| 2023-03-07 00:27 | 2023-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Greenleaf Peter | Director, Officer; Chief Executive Officer | Pharmaceutical Preparations | SALE | $8.94 | 32,750 | $292,785 | 982,968 | -3.2% |
| 2023-03-07 00:29 | 2023-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | MILNE GEORGE M JR | Director | Pharmaceutical Preparations | BUY | $8.91 | 20,000 | $178,284 | 70,000 | +40.0% |
| 2022-11-24 00:04 | 2022-11-21 | AUPH | Aurinia Pharmaceuticals Inc. | Donley Matthew Maxwell | Officer; Ex VP, Internal Operations | Pharmaceutical Preparations | BUY | $4.66 | 10,000 | $46,600 | 27,927 | +55.8% |
| 2022-11-15 00:31 | 2022-11-09 | AUPH | Aurinia Pharmaceuticals Inc. | Habig Scott Michael | Officer; Chief Commercial Officer | Pharmaceutical Preparations | BUY | $5.02 | 5,000 | $25,075 | 5,000 | +100.0% |
| 2022-11-10 00:05 | 2022-11-07 | AUPH | Aurinia Pharmaceuticals Inc. | Martin Michael Robert | Officer; Chief Business Officer | Pharmaceutical Preparations | BUY | $5.16 | 30,000 | $154,800 | 89,512 | +50.4% |
| 2022-03-12 00:05 | 2022-03-09 | AUPH | Aurinia Pharmaceuticals Inc. | MacKay-Dunn R. Hector | Director | Pharmaceutical Preparations | BUY | $11.00 | 5,000 | $54,985 | 11,000 | +83.3% |
| 2022-03-09 00:06 | 2022-03-04 | AUPH | Aurinia Pharmaceuticals Inc. | MILNE GEORGE M JR | Director | Pharmaceutical Preparations | BUY | $10.82 | 5,000 | $54,100 | 50,000 | +11.1% |
| 2022-03-05 00:13 | 2022-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Martin Michael Robert | Officer; Chief Business Officer | Pharmaceutical Preparations | SALE | $12.01 | 4,849 | $58,236 | 59,512 | -7.5% |
| 2022-03-05 00:12 | 2022-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Donley Matthew Maxwell | Officer; Ex VP, Intern'l Operations | Pharmaceutical Preparations | SALE | $12.01 | 3,052 | $36,655 | 16,224 | -15.8% |
| 2022-03-05 00:12 | 2022-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Miller Joseph M | Officer; Chief Financial Officer | Pharmaceutical Preparations | SALE | $12.01 | 3,060 | $36,751 | 6,610 | -31.6% |
| 2022-03-05 00:11 | 2022-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Colao Massimilano | Officer; Chief Commercial Officer | Pharmaceutical Preparations | SALE | $12.01 | 3,205 | $38,492 | 13,495 | -19.2% |
| 2022-03-05 00:10 | 2022-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Solomons Neil | Officer; Chief Medical Officer | Pharmaceutical Preparations | SALE | $12.01 | 4,846 | $58,200 | 90,953 | -5.1% |
| 2022-03-05 00:10 | 2022-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Huizinga Robert Bindert | Officer; EVP of Research | Pharmaceutical Preparations | SALE | $12.01 | 4,849 | $58,236 | 69,379 | -6.5% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.